glp-1 launch youtheory® & Weight Loss Expert Doctor-Formulated Support – Youtheory GLP-1 Medications for Weight Loss:
Description
This builds on his work to understand 'how circulating GLP-1 can produce multiple actions, both directly and indirectly, on multiple organs' which he has pursued for many years with colleagues (McLean, Wong, Campbell)
FDA removed tirzepatide from the shortage list in October 2024 and semaglutide in February 2025
The 10mg/ml concentration requires splitting into two injections
These injections replicate the glucagon-like peptide-1 (GLP-1) hormone
